AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023- Evolving Opportunities with Boehringer Ingelheim International GmbH and Catalent| Technavio

November 14, 2019
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023- Evolving Opportunities with Boehringer Ingelheim International GmbH and Catalent| Technavio
Global Pharmaceutical Contract Research and Manufacturing (CRAM) Market 2019-2023- Evolving Opportunities with Boehringer Ingelheim International GmbH and Catalent| Technavio

LONDON--(BUSINESS WIRE)--Nov 14, 2019--

The global pharmaceutical contract research and manufacturing (CRAM) market size will grow by USD 62.67 billion during 2019-2023. This market report provides a detailed analysis of the market by service (CRO and CMO) and geography (Asia, Europe, North America, and ROW).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191114005366/en/

Technavio has announced its latest market research report titled global pharmaceutical contract research and manufacturing (CRAM) market 2019-2023 (Graphic: Business Wire)

To learn more about the global trends impacting the future of market @Request for Free Sample Report

Vendor Landscape

Boehringer Ingelheim International GmbH, Catalent, Inc, IQVIA, Lonza, and Thermo Fisher Scientific Inc are among the vendors who have a strong position in the global market. While Charles River, Dr. Reddy’s Laboratories Ltd., Consort Medical, ICON plc, and LUPIN a favorable position in the global market.

Boehringer Ingelheim International GmbH is one of the leading vendors in the pharmaceutical CRAM market sphere. The company’s newest product offerings include:

Get A Free Sample Analysis from thePharmaceutical CRAM Market

Catalent is another leading vendor in the pharmaceutical CRAM market sphere. In line with the market, the company’s newest product offerings include:

IQVIA is another leading vendor in the pharmaceutical CRAM market. In line with the market, the company’s newest product offerings include:

Register for a free trial today and gain instant access to 17,000+ market research reports.

Technavio’s SUBSCRIPTION platform

KEY TOPICS COVERED:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: MARKET LANDSCAPE

PART 04: MARKET SIZING

PART 05: FIVE FORCES ANALYSIS

PART 06: MARKET SEGMENTATION BY SERVICE

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

PART 09: DRIVERS AND CHALLENGES

PART 10: MARKET TRENDS

PART 11: VENDOR LANDSCAPE

PART 12: VENDOR ANALYSIS

PART 13: APPENDIX

For more information about this report visithttps://www.technavio.com/report/global-pharmaceutical-contract-research-and-manufacturing-cram-market-industry-analysis

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

Technavio is an international consulting and market research firm dedicated to empowering confident strategic decisions within the medical device, dental, pharmaceutical and more Healthcare industries.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191114005366/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

Email: media@technavio.com

Website: https://www.technavio.com 

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 11/14/2019 07:07 AM/DISC: 11/14/2019 07:07 AM

http://www.businesswire.com/news/home/20191114005366/en